Stay updated on Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial page
- Check6 days agoChange DetectedLocations section now includes additional study sites across multiple countries and regions, expanding geographic coverage. This update broadens access for potential participants and may affect enrollment logistics.SummaryDifference3%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 in the page footer.SummaryDifference0.0%

- Check35 days agoChange DetectedAdditions clarify that Publications are provided voluntarily and are auto-filled from PubMed. Deletions remove older phrasing about these sources. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedThe Locations list adds Tainan, Taiwan, 704 and removes Tainan City, Taiwan, 704; a government funding notice block is deleted.SummaryDifference0.1%

- Check57 days agoChange Detected- Added a new publication citation for KEYNOTE-585 final analysis (Shitara et al., J Clin Oncol 2025) to the Publications section. - Removed the online-ahead-of-print citation for the same study. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check86 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision tag, replacing the previous v3.1.0. This updates core content with current operating status guidance and versioning.SummaryDifference1%

Stay in the know with updates to Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial page.